Abstract:Objective:To compare the efficacy and safety of risperidone and chlorpromazine in treatment of first-episode schizo phrenia.Methods:It is a one year naturalistic study.One hundred and eighty-six patients with first-episode of schizophrenia were included who met ICD-10 criteria for schizophrenia or schizophreniform disorder and received integrated treatment(risper- idone or chlorpromazine plus psychosocial education,family psycho-education).There were 131 patients included in the risperi- done group and 55 included in the chlorpromazine group.Written informed consent was obtained from the patients or their legal guardians.Clinical stains was assessed with the Positive and Negative Symptom Scale(PANSS).the Treatment Emergent Symptom Scale(TESS)and the time to the discontinuation of treatment.The Short Form-36(sf-36)was used to assess the quality of life.Results:Thirty-five percent in the rieperdone group partially completed follow-up assessments and 51% in the chlor promazine group did.the difference of the rates between the two groups was significant.Response rate was defined as improvement in PANSS total score of≥50%.The response rates at the end of 2.3.6.8.12 months in the risperidone group were 29.1%.41.8%. 50.9%.50.9%.56.4% and in the chlorpromazine group were 40.5%.46.6%.57.3%.64.1%.62.6%.respectively.There was no significant difference of the response rate at any of the follow up time between the two groups.The relapse rates were similar as 20. 2% in the risperidone group and 20.6% in the comparing group.The time to the discontinuation of treatment for any cause was longer in the risperidone group than in the chlorpromazine gronp.However.the difference was not significant.Risperidone was associated with lower symptoms of tremor,constipation,sialorrhea(P0.01)and also associated with more frequent reports of agitation,de- pression,insomnia,gastrointestinal disturbance,menstrual disorder(P0.05).There are significant improvements in 6 factors (role of physics,body pain.globe health,social function,role of emotion and mental heahh)of sf 36 in risperidone group and only 2 factory(social function,role of emotion)in the comparative group.Conclusion:The efficacy of risperidone is as same as that of chlorpromazine in the treatment of first-episode schizophrenia,yet the rates of some adverse events are different in the two groups and risperidone may enhance the quality of life from more aspects.

Efficacy of very low dosage of risperidone in the treatment of first-episode schizophrenia

Efficacy and Safety of Long-Acting Risperidone on Early Onset Schizophrenia in Adolescent Patients

A double blinded multicenter clinical trial for evaluating the efficacy and safety of aripiprazole and risperidone in the treatment of schizophrenia

Study on Efficacy and Safety of Risperidone in Treatment of Different Kinds of Schizophrenia

Observation on Clinical Efficacy of Risperidone in Treatment of Children and Adolescents with Schizophrenia

Effect of Risperidone Monotherapy on Dynamic Functional Connectivity of Insular Subdivisions in Treatment-Naive, First-Episode Schizophrenia

One Year Follow-up Study: Risperidone and Chlorpromazine for Patients with First-episode Schizophrenia

Clinical Study of Risperidone Orally Disintegrating Tabiets and Clozapine in the Treatment of Schizophrenia

An Open-Label Randomised Comparison of Aripiprazole, Olanzapine and Risperidone for the Acute Treatment of First-Episode Schizophrenia: Eight-week Outcomes.

Cognitive function changes with risperidone monotherapy and their relationship to psychotic symptoms in treatment-na?ve first-episode schizophrenia patients

Efficacy and Safety of the Domestic Risperidone in Patients with Schizophrenia:a Randomized,Double-blind,Controlled Trial

The Effects of Antipsychotics on Serum Prolactin in the First-Episode Schizophrenia Patients

Aripiprazole and risperidone in treatment of the patients with schizophrenia: a randomly clinical trial

N-acetylaspartate reduction in the medial prefrontal cortex following 8 weeks of risperidone treatment in first-episode drug-naïve schizophrenia patients.

A Multicenter Study of Risperidone Treatment for Acute Agitation in Patients with Schizophrenia

Risperidone Versus Haloperidol in the Treatment of Acute Exacerbations of Chronic Inpatients with Schizophrenia: a Randomized Double-Blind Study

Double-blind Comparison of Ziprasidone and Risperidone in the Treatment of Chinese Patients with Acute Exacerbation of Schizophrenia

THERAPEUTIC AND ADVERSE EFFECTS OF RISPERIDONE IN TREATMENT OF DIFFERENT GENDER PATIENTS WITH SCHIZOPHRENIA

Quetiapine and risperdal in the treatment of schizophrenia:an one-year follow up study.

Short-term Effects of Risperidone Monotherapy on Spontaneous Brain Activity in First-episode Treatment-naïve Schizophrenia Patients: A Longitudinal Fmri Study

Double-blind,double-dummy and randomized controlled study of aripiprazole in the treatment of acute schizophrenia